NCT00311350

Study Evaluating the Safety of MOA-728 Administered Orally to Healthy Subjects

Ascending Multiple Dose Study of the Safety, Tolerability, and Pharmacokinetics of MOA-728 Administered Orally to Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (planned)
• Sponsor: Bausch Health Americas, Inc. · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This is the first multiple-dose experience in humans with MOA-728 in an oral formulation. This study will provide an assessment of the safety, tolerability, and pharmacokinetics (PK) of MOA-728 following administration of ascending multiple oral doses to healthy subjects.

Conditions

• Postoperative Complications
• Constipation

Interventions

Type	Name	Description
DRUG	MOA-728

Timeline

• Start date: 2006-03-01
• Completion: 2006-08-01
• First posted: 2006-04-05
• Last updated: 2019-11-25

Locations

1 site across 1 country: United States